Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder
Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in...
Saved in:
| Published in | PloS one Vol. 16; no. 12; p. e0262129 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
31.12.2021
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice.
The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017.
In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes.
In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. |
|---|---|
| AbstractList | Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice.BACKGROUNDBipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice.The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017.METHODSThe multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017.In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes.RESULTSIn total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes.In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes.CONCLUSIONSIn Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. Background Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice. Methods The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017. Results In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes. Conclusions In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice. The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017. In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes. In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice. The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017. In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes. In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. Background Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice. Methods The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017. Results In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes. Conclusions In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. BackgroundBipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice.MethodsThe multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017.ResultsIn total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes.ConclusionsIn Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes. |
| Audience | Academic |
| Author | Tokumitsu, Keita Yoshimura, Reiji Edagawa, Koji Azekawa, Takaharu Goto, Eiichiro Kikuchi, Toshiaki Shimoda, Kazutaka Tsuboi, Takashi Nakagawa, Atsuo Norio, Yasui-Furukori Kato, Masaki Ueda, Hitoshi Watanabe, Koichiro Watanabe, Yoichiro Adachi, Naoto Katsumoto, Eiichi Hongo, Seiji Miki, Kazuhira Kubota, Yukihisa |
| AuthorAffiliation | Federico II University of Naples, ITALY 3 The Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan 4 Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan 6 Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan 7 Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan 2 The Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan 5 Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan 1 Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan |
| AuthorAffiliation_xml | – name: 3 The Japanese Association of Neuro-Psychiatric Clinics, Tokyo, Japan – name: 2 The Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan – name: 1 Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan – name: 4 Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan – name: 7 Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan – name: 5 Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan – name: Federico II University of Naples, ITALY – name: 6 Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan |
| Author_xml | – sequence: 1 givenname: Keita orcidid: 0000-0001-6747-4348 surname: Tokumitsu fullname: Tokumitsu, Keita – sequence: 2 givenname: Yasui-Furukori orcidid: 0000-0002-4414-3770 surname: Norio fullname: Norio, Yasui-Furukori – sequence: 3 givenname: Naoto surname: Adachi fullname: Adachi, Naoto – sequence: 4 givenname: Yukihisa surname: Kubota fullname: Kubota, Yukihisa – sequence: 5 givenname: Yoichiro surname: Watanabe fullname: Watanabe, Yoichiro – sequence: 6 givenname: Kazuhira surname: Miki fullname: Miki, Kazuhira – sequence: 7 givenname: Takaharu surname: Azekawa fullname: Azekawa, Takaharu – sequence: 8 givenname: Koji surname: Edagawa fullname: Edagawa, Koji – sequence: 9 givenname: Eiichi surname: Katsumoto fullname: Katsumoto, Eiichi – sequence: 10 givenname: Seiji surname: Hongo fullname: Hongo, Seiji – sequence: 11 givenname: Eiichiro surname: Goto fullname: Goto, Eiichiro – sequence: 12 givenname: Hitoshi surname: Ueda fullname: Ueda, Hitoshi – sequence: 13 givenname: Masaki orcidid: 0000-0001-6727-7272 surname: Kato fullname: Kato, Masaki – sequence: 14 givenname: Atsuo surname: Nakagawa fullname: Nakagawa, Atsuo – sequence: 15 givenname: Toshiaki surname: Kikuchi fullname: Kikuchi, Toshiaki – sequence: 16 givenname: Takashi surname: Tsuboi fullname: Tsuboi, Takashi – sequence: 17 givenname: Koichiro surname: Watanabe fullname: Watanabe, Koichiro – sequence: 18 givenname: Kazutaka surname: Shimoda fullname: Shimoda, Kazutaka – sequence: 19 givenname: Reiji surname: Yoshimura fullname: Yoshimura, Reiji |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34972188$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1lr3DAQx01JaY72G5TWUCjtw24syZalPhRC6LEQCKTHq9DlXQXZciS5ab595ay3rEMoRQ8So9_852DmODvoXKez7CUolgDV4PTaDb7jdtkn87KAGAJIn2RHgCK4wLBAB3vvw-w4hOuiqBDB-Fl2iEpaQ0DIUSauNLeLW-etyqU1nZHc5r3XysjofMhdk7c8WU83d727f-W6N8EpHXLeum6duyH2PBrdxZDfmrjJhemd5T5XCfNK--fZ04bboF9M90n24_On7-dfFxeXX1bnZxcLiSmMCyGJAilXihGRtBFcao5EVehG1AIDSbiCddnAJuUtFWkoT10oISG6qQglEJ1kr7e6vXWBTe0JDGJQ4YJSQhKx2hLK8WvWe9Nyf8ccN-ze4PyacR-NtJph2GDOFRI1wSUSVIga0RKUqKpRBWGdtD5O0QbRaiVT_Z7bmej8pzMbtna_GKkBratR4N0k4N3NoENkrQlSW8s77YZt3hTCCqOEvnmAPl7dRK15KsB0jUtx5SjKznD6x0lpDLt8hEpH6dbINEuNSfaZw_uZQ2Ki_h3XfAiBrb5d_T97-XPOvt1jN2kM4yY4O0TjujAHX-13-m-Ld0OcgA9bQHoXgtcNkybyUSeVZiwDBRs3Ztc0Nm4MmzYmOZcPnHf6_3T7AwH-GvQ |
| CitedBy_id | crossref_primary_10_1186_s12991_022_00415_0 crossref_primary_10_1029_2024GH001165 crossref_primary_10_3389_fpsyt_2023_1078045 crossref_primary_10_1016_j_bpsc_2024_06_005 crossref_primary_10_1186_s12991_023_00487_6 crossref_primary_10_3389_fpsyt_2023_1183782 crossref_primary_10_1371_journal_pone_0272758 |
| Cites_doi | 10.1155/2013/297087 10.1016/j.cpr.2017.11.006 10.1001/archpsyc.59.6.530 10.1001/archpsyc.60.3.261 10.1016/j.jpsychires.2020.09.030 10.1001/archgenpsychiatry.2011.12 10.1016/j.jpsychires.2015.04.014 10.1111/bdi.12905 10.1192/bjp.2019.16 10.1016/j.drugalcdep.2013.06.011 10.1176/appi.ajp.161.2.262 10.4088/JCP.v68n0811 10.4088/JCP.v69n0608 10.1016/j.jpsychires.2009.09.011 10.1016/S0010-440X(96)90568-4 10.1186/s12888-020-02967-5 10.1176/appi.books.9780890425596 10.1038/bmt.2012.244 10.1111/bdi.12612 10.4088/JCP.v69n1115 10.1097/00004714-199612000-00003 10.1176/appi.ajp.2007.05081484 10.1016/j.biopsych.2004.09.022 10.2147/NDT.S100846 10.1001/archgenpsychiatry.2009.36 10.1111/bdi.12371 10.4088/JCP.13r08905 10.1111/j.1399-5618.2005.00179.x 10.1038/nrdp.2018.8 10.1016/j.jad.2017.08.011 10.1080/03610911003650383 10.1016/j.jad.2017.07.023 10.1034/j.1399-5618.2003.00028.x 10.1056/NEJMra1906193 10.1186/s40345-018-0133-9 10.1097/01.psy.0000151489.36347.18 10.1111/bdi.12609 10.1016/j.jad.2018.04.097 10.1176/appi.ajp.2014.13111501 10.1176/appi.ajp.2020.19091000 10.1016/j.jad.2018.02.085 10.2147/NDT.S246136 10.9758/cpn.2020.18.4.599 10.1016/j.jad.2020.03.030 10.1016/j.jad.2016.01.040 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 Public Library of Science 2021 Tokumitsu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Tokumitsu et al 2021 Tokumitsu et al |
| Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Tokumitsu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Tokumitsu et al 2021 Tokumitsu et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0262129 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database (NC LIVE) Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Database Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Materials Science Database (NC LIVE) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest Engineering Database (NC LIVE) Nursing & Allied Health Premium ProQuest Advanced Technologies & Aerospace Database (NC LIVE) ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine |
| DocumentTitleAlternate | Clinical predictors of manic episodes |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2615609988 oai_doaj_org_article_62f6aad3b78643b9bb73941435735227 PMC8719757 A688366337 34972188 10_1371_journal_pone_0262129 |
| Genre | Multicenter Study Research Support, Non-U.S. Gov't Journal Article Observational Study |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: ; grantid: 2016-2 – fundername: ; grantid: 2017-4 – fundername: ; grantid: 2019-3 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS PUEGO RC3 7X8 5PM AAPBV ABPTK |
| ID | FETCH-LOGICAL-c692t-bc8d12039638c9fbacea3b50efb7b61c8ad274f2f188cd8f9a3714288ef589823 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Oct 01 00:11:28 EDT 2023 Wed Aug 27 01:31:33 EDT 2025 Thu Aug 21 14:06:40 EDT 2025 Tue Aug 05 10:39:53 EDT 2025 Sat Aug 23 14:23:24 EDT 2025 Tue Jun 17 21:23:46 EDT 2025 Tue Jun 10 20:29:35 EDT 2025 Fri Jun 27 04:10:41 EDT 2025 Fri Jun 27 04:44:32 EDT 2025 Thu May 22 21:14:48 EDT 2025 Wed Feb 19 02:28:17 EST 2025 Thu Apr 24 23:00:57 EDT 2025 Tue Jul 01 01:40:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-bc8d12039638c9fbacea3b50efb7b61c8ad274f2f188cd8f9a3714288ef589823 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Competing Interests: Yasui-Furukori has received grant/research support or honoraria from and has been a speaker for Dainippon-Sumitomo Pharma, Mochida Pharmaceutical, MSD, and Otsuka Pharmaceutical. Shimoda has received research support from Novartis Pharma, Dainippon Sumitomo Pharma, Astellas Pharma, Meiji Seika Pharma, Eisai, Pfizer, Otsuka Pharmaceutical, Daiichi Sankyo, and Takeda Pharmaceutical and honoraria from Eisai, Mitsubishi Tanabe Pharma, Takeda Pharmaceutical, Meiji Seika Pharma, Janssen Pharmaceutical, Shionogi, Dainippon Sumitomo Pharma, Daiichi Sankyo, and Pfizer. Yoshimura has received speaker honoraria from Eli Lilly, Janssen, Dainippon Sumitomo, Otsuka, Meiji, Pfizer and Shionogi. Kato has received grant funding from the Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation and the Japan Research Foundation for Clinical Pharmacology and has received speaker honoraria from Dainippon-Sumitomo Pharma, Otsuka, Meiji-Seika Pharma, Eli Lilly, MSD K.K., GlaxoSmithKline, Pfizer, Janssen Pharmaceutical, Shionogi, Mitsubishi Tanabe Pharma, Takeda Pharmaceutical and Ono Pharmaceutical. Azegawa has received speaker honoraria from Eli Lilly, Otsuka Pharmaceutical, and Pfizer. Ueda has received manuscript fees or speaker honoraria from Eli Lilly, Janssen Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, and Yoshitomi Yakuhin. Edagawa has received speaker honoraria from Eli Lilly, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, Kyowa and Yoshitomi Yakuhin. Katsumoto has received speaker honoraria from Daiichi Sankyo, Eisai, Eli Lilly, Janssen Pharmaceutical, Kyowa Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, and UCB. Kubota has received consultant fees from Pfizer and Meiji-Seika Pharma and speaker honoraria from Meiji-Seika Pharma, Eli Lilly, Janssen Pharmaceutical, Dainippon Sumitomo Pharma, Mitsubishi Tanabe Pharma, Yoshitomi Yakuhin, Otsuka Pharmaceutical, and Eisai. Goto has received manuscript fees or speaker honoraria from Eli Lilly, Janssen Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, and Sumitomo Dainippon Pharma. Hongo has received manuscript fees or speaker honoraria from Eli Lilly, Janssen Pharmaceutical, Kyowa Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Sumitomo Dainippon Pharma, and Yoshitomi Yakuhin. Tsuboi has received consultant fees from Pfizer and speaker honoraria from Eli Lilly, Meiji-Seika Pharma, MSD, Janssen Pharmaceutical, Dainippon Sumitomo Pharma, Mitsubishi Tanabe Pharma, Yoshitomi Yakuhin, Mochida Pharmaceutical, Otsuka Pharmaceutical, Kyowa Pharmaceutical, and Takeda Pharmaceutical. Nakagawa has received lecture fees from Pfizer, Eli Lilly, Otsuka, Janssen Pharmaceutical, Mitsubishi Tanabe, Mochida, Dainippon Sumitomo and NTT Docomo and has served on advisory boards for Takeda, Meiji Seika and Tsumura. Kikuchi has received consultant fees from Takeda Pharmaceutical and the Center for Cognitive Behavioral Therapy and Training. Watanabe has received manuscript fees or speaker honoraria from Daiichi Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Kyowa Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, Pfizer, Shionogi, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, and Yoshitomi Yakuhin; has received research/grant support from Astellas Pharma, Daiichi Sankyo, Eisai, MSD, Mitsubishi Tanabe Pharma, Meiji Seika Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, and Sumitomo Dainippon Pharma; and is a consultant for Eisai, Eli Lilly, Kyowa Pharmaceutical, Otsuka Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical, and Takeda Pharmaceutical. |
| ORCID | 0000-0002-4414-3770 0000-0001-6727-7272 0000-0001-6747-4348 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0262129 |
| PMID | 34972188 |
| PQID | 2615609988 |
| PQPubID | 1436336 |
| PageCount | e0262129 |
| ParticipantIDs | plos_journals_2615609988 doaj_primary_oai_doaj_org_article_62f6aad3b78643b9bb73941435735227 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8719757 proquest_miscellaneous_2615922563 proquest_journals_2615609988 gale_infotracmisc_A688366337 gale_infotracacademiconefile_A688366337 gale_incontextgauss_ISR_A688366337 gale_incontextgauss_IOV_A688366337 gale_healthsolutions_A688366337 pubmed_primary_34972188 crossref_citationtrail_10_1371_journal_pone_0262129 crossref_primary_10_1371_journal_pone_0262129 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-31 |
| PublicationDateYYYYMMDD | 2021-12-31 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-31 day: 31 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2021 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | T Tsuboi (pone.0262129.ref011) 2020; 16 B Liu (pone.0262129.ref047) 2017; 223 A Bahji (pone.0262129.ref038) 2020; 269 S Seedat (pone.0262129.ref005) 2009; 66 MJ Gitlin (pone.0262129.ref046) 2018; 6 AH Fan (pone.0262129.ref022) 2008; 69 E Vieta (pone.0262129.ref006) 2018; 4 M Fornaro (pone.0262129.ref021) 2016; 195 HA Swartz (pone.0262129.ref024) 2005; 7 T Niitsu (pone.0262129.ref016) 2015; 66–67 IM Anderson (pone.0262129.ref002) 2012; 345 A Okasha (pone.0262129.ref020) 1996; 37 N Yasui-Furukori (pone.0262129.ref012) 2020; 18 AF Carvalho (pone.0262129.ref019) 2014; 75 LL Judd (pone.0262129.ref036) 2003; 60 IMM Lima (pone.0262129.ref035) 2018; 59 LV Kessing (pone.0262129.ref043) 2016; 18 Z Mousavi (pone.0262129.ref045) 2018; 236 CJ Ruggero (pone.0262129.ref028) 2010; 44 RH Howland (pone.0262129.ref040) 1996; 16 A Kenneson (pone.0262129.ref029) 2013; 133 H Chen (pone.0262129.ref049) 2010; 39 EL George (pone.0262129.ref025) 2003; 5 LL Judd (pone.0262129.ref037) 2002; 59 A Viktorin (pone.0262129.ref039) 2014; 171 K Tokumitsu (pone.0262129.ref010) 2020; 20 AA Ghouse (pone.0262129.ref026) 2013; 2013 GE Simon (pone.0262129.ref007) 2007; 68 World Health Organization (pone.0262129.ref003) 1992 KR Krishnan (pone.0262129.ref031) 2005; 67 DJ Martino (pone.0262129.ref034) 2018; 225 Y. Kanda (pone.0262129.ref015) 2013; 48 M Fornaro (pone.0262129.ref008) 2018; 20 M Fornaro (pone.0262129.ref048) 2016; 12 AF Carvalho (pone.0262129.ref001) 2020; 383 LN Yatham (pone.0262129.ref044) 2018; 20 M Fornaro (pone.0262129.ref009) 2018; 234 KR Merikangas (pone.0262129.ref004) 2011; 68 CD Schneck (pone.0262129.ref018) 2008; 165 O Friborg (pone.0262129.ref023) 2014 American Psychiatric Association (pone.0262129.ref032) 2013 M Zimmerman (pone.0262129.ref027) 2008; 69 M Kato (pone.0262129.ref014) 2020; 131 TG Rhee (pone.0262129.ref042) 2020; 177 A Martínez-Arán (pone.0262129.ref033) 2004; 161 N Adachi (pone.0262129.ref013) 2020 JR Calabrese (pone.0262129.ref017) 2004; 56 LM Lyall (pone.0262129.ref041) 2019; 215 K Gordon-Smith (pone.0262129.ref030) 2020; 22 |
| References_xml | – volume: 2013 year: 2013 ident: pone.0262129.ref026 article-title: Overdiagnosis of bipolar disorder: a critical analysis of the literature. publication-title: The Scientific World Journal doi: 10.1155/2013/297087 – volume: 59 start-page: 126 year: 2018 ident: pone.0262129.ref035 article-title: Cognitive deficits in bipolar disorders: Implications for emotion. publication-title: Clinical psychology reviewPubMed Central PMCID doi: 10.1016/j.cpr.2017.11.006 – volume: 59 start-page: 530 issue: 6 year: 2002 ident: pone.0262129.ref037 article-title: The long-term natural history of the weekly symptomatic status of bipolar I disorder publication-title: Archives of general psychiatry doi: 10.1001/archpsyc.59.6.530 – volume: 60 start-page: 261 issue: 3 year: 2003 ident: pone.0262129.ref036 article-title: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder publication-title: Archives of general psychiatry doi: 10.1001/archpsyc.60.3.261 – volume: 345 start-page: e8508 year: 2012 ident: pone.0262129.ref002 article-title: Bipolar disorder. publication-title: BMJ (Clinical research ed). – volume: 131 start-page: 228 year: 2020 ident: pone.0262129.ref014 article-title: Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI). publication-title: Journal of psychiatric research doi: 10.1016/j.jpsychires.2020.09.030 – volume: 68 start-page: 241 issue: 3 year: 2011 ident: pone.0262129.ref004 article-title: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. publication-title: Archives of general psychiatry doi: 10.1001/archgenpsychiatry.2011.12 – volume: 66–67 start-page: 45 year: 2015 ident: pone.0262129.ref016 article-title: Predictors of switch from depression to mania in bipolar disorder publication-title: Journal of psychiatric research doi: 10.1016/j.jpsychires.2015.04.014 – volume: 22 start-page: 731 issue: 7 year: 2020 ident: pone.0262129.ref030 article-title: Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: Findings from the UK Bipolar Disorder Research Network. publication-title: Bipolar disorders doi: 10.1111/bdi.12905 – volume: 215 start-page: 415 issue: 1 year: 2019 ident: pone.0262129.ref041 article-title: Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland. publication-title: The British journal of psychiatry: the journal of mental science doi: 10.1192/bjp.2019.16 – volume: 133 start-page: 338 issue: 2 year: 2013 ident: pone.0262129.ref029 article-title: Substance use disorders increase the odds of subsequent mood disorders publication-title: Drug and Alcohol Dependence doi: 10.1016/j.drugalcdep.2013.06.011 – volume: 161 start-page: 262 issue: 2 year: 2004 ident: pone.0262129.ref033 article-title: Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder publication-title: The American journal of psychiatry doi: 10.1176/appi.ajp.161.2.262 – volume: 68 start-page: 1237 issue: 8 year: 2007 ident: pone.0262129.ref007 article-title: Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression publication-title: The Journal of clinical psychiatry doi: 10.4088/JCP.v68n0811 – volume: 69 start-page: 935 issue: 6 year: 2008 ident: pone.0262129.ref027 article-title: Is bipolar disorder overdiagnosed? publication-title: The Journal of clinical psychiatry doi: 10.4088/JCP.v69n0608 – volume: 44 start-page: 405 issue: 6 year: 2010 ident: pone.0262129.ref028 article-title: Borderline personality disorder and the misdiagnosis of bipolar disorder publication-title: Journal of psychiatric research doi: 10.1016/j.jpsychires.2009.09.011 – volume: 37 start-page: 95 issue: 2 year: 1996 ident: pone.0262129.ref020 article-title: Comorbidity of axis I and axis II diagnoses in a sample of Egyptian patients with neurotic disorders. publication-title: Comprehensive psychiatry doi: 10.1016/S0010-440X(96)90568-4 – volume: 20 start-page: 555 issue: 1 year: 2020 ident: pone.0262129.ref010 article-title: Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder. publication-title: BMC psychiatry doi: 10.1186/s12888-020-02967-5 – volume-title: Diagnostic and Statistical Manual of Mental Disorders year: 2013 ident: pone.0262129.ref032 doi: 10.1176/appi.books.9780890425596 – volume: 48 start-page: 452 issue: 3 year: 2013 ident: pone.0262129.ref015 article-title: Investigation of the freely available easy-to-use software ’EZR’ for medical statistics publication-title: Bone marrow transplantation doi: 10.1038/bmt.2012.244 – volume: 20 start-page: 195 issue: 3 year: 2018 ident: pone.0262129.ref008 article-title: Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis. publication-title: Bipolar disorders doi: 10.1111/bdi.12612 – start-page: e2764 year: 2020 ident: pone.0262129.ref013 article-title: Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients’ and practitioners’ parameters in the MUSUBI study. publication-title: Human psychopharmacology – volume: 69 start-page: 1794 issue: 11 year: 2008 ident: pone.0262129.ref022 article-title: Bipolar disorder and comorbid personality psychopathology: a review of the literature. publication-title: The Journal of clinical psychiatry doi: 10.4088/JCP.v69n1115 – volume: 16 start-page: 425 issue: 6 year: 1996 ident: pone.0262129.ref040 article-title: Induction of mania with serotonin reuptake inhibitors publication-title: Journal of clinical psychopharmacology doi: 10.1097/00004714-199612000-00003 – volume-title: International classification of diseases and related health problems, 10th revision. year: 1992 ident: pone.0262129.ref003 – volume: 165 start-page: 370 issue: 3 year: 2008 ident: pone.0262129.ref018 article-title: The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD publication-title: The American journal of psychiatry doi: 10.1176/appi.ajp.2007.05081484 – volume: 56 start-page: 957 issue: 12 year: 2004 ident: pone.0262129.ref017 article-title: Mood state at study entry as predictor of the polarity of relapse in bipolar disorder publication-title: Biological psychiatry doi: 10.1016/j.biopsych.2004.09.022 – volume: 12 start-page: 719 year: 2016 ident: pone.0262129.ref048 article-title: Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review. publication-title: Neuropsychiatr Dis Treat doi: 10.2147/NDT.S100846 – volume: 66 start-page: 785 issue: 7 year: 2009 ident: pone.0262129.ref005 article-title: Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. publication-title: Archives of general psychiatry doi: 10.1001/archgenpsychiatry.2009.36 – volume: 18 start-page: 174 issue: 2 year: 2016 ident: pone.0262129.ref043 article-title: Nationwide and population-based prescription patterns in bipolar disorder. publication-title: Bipolar disorders doi: 10.1111/bdi.12371 – volume: 75 start-page: e578 issue: 6 year: 2014 ident: pone.0262129.ref019 article-title: Rapid cycling in bipolar disorder: a systematic review. publication-title: The Journal of clinical psychiatry doi: 10.4088/JCP.13r08905 – volume: 7 start-page: 192 issue: 2 year: 2005 ident: pone.0262129.ref024 article-title: Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. publication-title: Bipolar disorders. doi: 10.1111/j.1399-5618.2005.00179.x – volume: 4 start-page: 18008 year: 2018 ident: pone.0262129.ref006 article-title: Bipolar disorders. publication-title: Nature reviews Disease primers doi: 10.1038/nrdp.2018.8 – volume: 225 start-page: 250 year: 2018 ident: pone.0262129.ref034 article-title: Longitudinal relationship between clinical course and neurocognitive impairments in bipolar disorder publication-title: Journal of affective disorders doi: 10.1016/j.jad.2017.08.011 – volume: 39 start-page: 860 year: 2010 ident: pone.0262129.ref049 article-title: How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies. publication-title: Communications in Statistics—Simulation and Computation. doi: 10.1080/03610911003650383 – volume: 223 start-page: 41 year: 2017 ident: pone.0262129.ref047 article-title: Efficacy and safety of long-term antidepressant treatment for bipolar disorders—A meta-analysis of randomized controlled trials publication-title: Journal of affective disorders doi: 10.1016/j.jad.2017.07.023 – volume: 5 start-page: 115 issue: 2 year: 2003 ident: pone.0262129.ref025 article-title: The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. publication-title: Bipolar disorders doi: 10.1034/j.1399-5618.2003.00028.x – volume: 383 start-page: 58 issue: 1 year: 2020 ident: pone.0262129.ref001 article-title: Bipolar Disorder. publication-title: The New England journal of medicine doi: 10.1056/NEJMra1906193 – volume: 6 start-page: 25 issue: 1 year: 2018 ident: pone.0262129.ref046 article-title: Antidepressants in bipolar depression: an enduring controversy. publication-title: International journal of bipolar disorders doi: 10.1186/s40345-018-0133-9 – volume: 67 start-page: 1 issue: 1 year: 2005 ident: pone.0262129.ref031 article-title: Psychiatric and medical comorbidities of bipolar disorder. publication-title: Psychosomatic medicine doi: 10.1097/01.psy.0000151489.36347.18 – volume: 20 start-page: 97 issue: 2 year: 2018 ident: pone.0262129.ref044 article-title: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. publication-title: Bipolar disorders. doi: 10.1111/bdi.12609 – volume: 236 start-page: 136 year: 2018 ident: pone.0262129.ref045 article-title: Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data publication-title: Journal of affective disorders doi: 10.1016/j.jad.2018.04.097 – volume: 171 start-page: 1067 issue: 10 year: 2014 ident: pone.0262129.ref039 article-title: The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer publication-title: The American journal of psychiatry doi: 10.1176/appi.ajp.2014.13111501 – volume: 177 start-page: 706 issue: 8 year: 2020 ident: pone.0262129.ref042 article-title: 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings publication-title: The American journal of psychiatry doi: 10.1176/appi.ajp.2020.19091000 – volume: 234 start-page: 131 year: 2018 ident: pone.0262129.ref009 article-title: Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants publication-title: Journal of affective disorders doi: 10.1016/j.jad.2018.02.085 – volume: 16 start-page: 881 year: 2020 ident: pone.0262129.ref011 article-title: Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI). publication-title: Neuropsychiatric disease and treatment doi: 10.2147/NDT.S246136 – volume: 18 start-page: 599 issue: 4 year: 2020 ident: pone.0262129.ref012 article-title: Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder publication-title: Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology doi: 10.9758/cpn.2020.18.4.599 – volume: 269 start-page: 154 year: 2020 ident: pone.0262129.ref038 article-title: Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis publication-title: Journal of affective disorders doi: 10.1016/j.jad.2020.03.030 – volume: 195 start-page: 105 year: 2016 ident: pone.0262129.ref021 article-title: The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis publication-title: Journal of affective disorders doi: 10.1016/j.jad.2016.01.040 – start-page: 152 year: 2014 ident: pone.0262129.ref023 article-title: Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010 publication-title: Journal of affective disorders |
| SSID | ssj0053866 |
| Score | 2.4215682 |
| Snippet | Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause... Background Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes... BackgroundBipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes... Background Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0262129 |
| SubjectTerms | Adolescent Adult Affect Age Factors Aged Aged, 80 and over Antidepressants Antidepressive Agents - therapeutic use Bipolar disorder Bipolar Disorder - complications Bipolar Disorder - physiopathology Body Mass Index Care and treatment Chi-square test Clinical medicine Comorbidity Complications and side effects Cycles Diagnosis Drug abuse Drug therapy Female Health risks Health services Health Status Indicators Humans Japan - epidemiology Male Mania - physiopathology Medicine Medicine and Health Sciences Mental disorders Middle Aged Mood Observational studies Outpatients Patients Personality Personality disorders Personality Disorders - complications Physical Sciences Polls & surveys Prevalence Psychiatry Psychotropic drugs Questionnaires Regression analysis Research and Analysis Methods Retrospective Studies Risk Risk analysis Risk factors Society Substance use disorder Substance-Related Disorders - complications Suicides & suicide attempts Surveys and Questionnaires Treatment Outcome Young Adult |
| SummonAdditionalLinks | – databaseName: Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8VxjAICXjI2sSJPx4HYhpIgDQY2ptlO_ZWaUqipX3gv9-d40YLmjQeeKmq-hy19-G7q-9-R8jbXApXGbnMVO3xmhFeLJdVJmSQQZlgy4gz--07Pz4tv55VZzdGfWFN2AAPPDBuwYvAjamZFRKcp1XWCqZK9PICY4fYRw4-b5tMDWcwWDHnqVGOiXyR5HLQtY0_gKwDzms1cUQRr388lWfdZdvfFnL-XTl5wxUdPSQPUgxJD4fvvkPu-eYR2UlW2tP3CUr6w2NiTyAOzCIqKt32QNLuCi9ncMoObQNF_Au3uPjTtfEd9d2qb2t4TBxDRNvNOkGv9hT_s6V21WE2TOsE2_mEnB59_vXpOEtTFTLHVbHOrJN1XiwZWp5TwRrnDbPV0gcrLM-dNDVkqqEIuZSuRoEhqF8hpQ-VVLJgT8msAT7uEloxcG68qHmw4Ax5qWpTQgrplfW-hHh4TtiWxdolyHGcfHGp4z2agNRj4JhGwegkmDnJxl3dALlxB_1HlN5Ii4DZ8QNQI53USN-lRnPyCmWvh-7T0ez1IZeSQVTGgOJNpEDQjAarcs7Npu_1lx-__4Ho58mE6F0iCi2ww5nUCQG_CcG4JpR7E0owfTdZ3kVN3XKl15AOQwQLGbSEnVvtvX359biMD8VKu8a3m4FGwSHP2Zw8G5R95CwrEesJd4uJGUxYP11pVhcRsxzyciUq8fx_yOoFuV9gZVGE29wjs_XVxr-E0HBt9-MpcA3NYGGV priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIiXaRsfKxtgEBLwkLWJE388oYEoA2kgDYb2FsWOvVWaktC0D_z33DlOIGgCXqqqPkfpne_LPv-OkOexFCYr5DxSpcVjRvjQXGaRkE46VTidepzZk0_8-Cz9eJ6dhw23NpRV9jbRG-qyNrhHPoNIH5wzJAfydfM9wq5ReLoaWmjcJLdi8DRY0iUX73tLDLrMebgux0Q8C9I5bOrKHkLuAVZbjdyRR-0fbPOkuarb6wLPP-snf3NIi22yFSJJetSJfofcsNUuuX0Szsp3yU5Q25a-DNjSr-4SfQqBYeRhUml_KZI2K5yEbXdo7SgCYpjZ5Y-m9t-obZZtXcJjfF8iWm_WAYu1pbiJS_WywfSYlgHH8x45W7z7-vY4Cm0WIsNVso60kWWczBmqolFOF8YWTGdz67TQPDayKCF1dYmLpTQlShBR_hIprcukkgm7TyYVsHSP0IyBt-NJyZ0G78hTVRYp5JRWaWtTCJCnhPXczk3AIMdWGFe5P1gTkIt0zMtRRnmQ0ZREw6ymw-D4B_0bFORAiwja_od6dZEHhcx54nhRlEwLCUGZVloLplKMHgXGpGJKnuAyyLvrqIMdyI-4lAzCNAYUzzwFomhUWKZzUWzaNv_w-dt_EH05HRG9CESuBnaYIlyNgP-E6FwjyoMRJdgCMxrew0Xbc6XNf2kNzOwX8vXDT4dhfCiW3lW23nQ0Cqw-Z1PyoFv3A2dZiuBPOFuMNGLE-vFItbz0IOaQqCuRiYd_f619cifBIiKPrHlAJuvVxj6CKHCtH3tV_wkLSl3C priority: 102 providerName: ProQuest |
| Title | Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34972188 https://www.proquest.com/docview/2615609988 https://www.proquest.com/docview/2615922563 https://pubmed.ncbi.nlm.nih.gov/PMC8719757 https://doaj.org/article/62f6aad3b78643b9bb73941435735227 http://dx.doi.org/10.1371/journal.pone.0262129 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYRSDkICHdM2XPx4Q2qaWgbSBCkV7i-LE3ipVSWhaib3wt3PnOhFBRezFiuKzpZx9vt_F9u8IeeULnsWpGHky17jNCIViIva4MMLI1KjI8syeX7CzWfTpMr7cIU3OVqfAemtoh_mkZsvF8OePm_dg8O9s1gbuN42GVVnoIcQUsBrLXbIHvoljToPzqN1XAOu2u5eIWjwWjEJ3me5fvXScleX0b1fuXrUo622w9O_TlX-4q8k9ctfhTHq8mRj7ZEcX98m-s-SavnF0028fEDUFrOhZ5lTa3JOk1RI3cDATDy0NRY6M7Oj6pirtE9XVvC5z6MamKqLleuXoWWuK_3WpmleoVpo7as-HZDYZfzs981zmBS9jMlh5KhO5D-pB68ykUWmm01DFI20UV8zPRJpDNGsC4wuR5TioSPwXCKFNLKQIwkekV4AeDwiNQ3CALMiZUeAwWSTzNIIwU0uldQSYuU_CRsVJ5mjJMTvGIrF7bRzCk43GEhyYxA1Mn3htq2pDy_Ef-RMcvVYWSbXti3J5lTgbTVhgWJrmoeICcJqSSvFQRggoOcJU3ifPceyTzQ3VdmlIjpkQISC3ECReWgkk1ijw5M5Vuq7r5OPn77cQ-jrtCL12QqYEdWSpuy0B34SEXR3Jw44kLA9Zp_oAZ2qjlTqBkBlQLkTZAlo2s3d79Yu2GjvF03iFLtcbGQmOgIV98ngz2VvNhhHyQWFr3jGDjuq7NcX82vKaQ-wuecyf3PrTn5I7AR4xsrybh6S3Wq71M8CIKzUgu_ySQylOfSwnHwZk72R88WU6sH9dBnZZwPLX-DdKk2yd |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRQIuiJZHA4UuCAQc3CR-7OOAUHmEhDZFKm3Vm_Hau22kyjZxItQ_xW9kZr02GFXApRcr8s5azuzsPLwz3xDybCh4GiVi4MlM4zEjXBQTkceFEUYmRoUWZ3a6z8ZH4aeT6GSF_GhqYTCtstGJVlFnRYrfyPvg6YNxhuBAvCm_edg1Ck9XmxYatVjs6ovvELJVryfvYX2f-_7ow-G7see6Cngpk_7CU6nIhv4gQMlLpVFJqpNARQNtFFdsmIokg0jN-GYoRJrhCyOonS-ENpGQAoEOQOVfCwOw5FiZPvrYaH7QHYy58jyY03fSsF0Wud6GWAeshOyYP9sloLUFq-V5UV3m6P6Zr_mbARzdJrec50p3alFbIys6XyfXp-5sfp2sOTVR0ZcOy_rVHaIOwBH1LCwrbYowaTnHSdjmhxaGIgBH2j-7KAv7i-pyVhUZPMb2QaLFcuGwXyuKH42pmpUYjtPM4YbeJUdXsgD3yGoOLN0gNArAujI_Y0aBNWahzJIQYlgtldYhOOQ9EjTcjlOHeY6tN85je5DHIfapmRfjGsVujXrEa2eVNebHP-jf4kK2tIjYbW8U89PYKYCY-YYlSRYoLsAJVFIpHsgQvVWOPjDvkS0Ug7guf231TrzDhAjALQyA4qmlQNSOHNOCTpNlVcWTz8f_QfTloEP0whGZAtiRJq4UA_4TooF1KDc7lKB70s7wBgptw5Uq_rVLYWYjyJcPP2mH8aGY6pfrYlnTSLAyLOiR-7Xct5wNQgSbwtm8syM6rO-O5LMzC5ou-FDyiD_4-2ttkRvjw-levDfZ331IbvqYwGRRPTfJ6mK-1I_AA12ox3bbU_L1qvXMTwcDm2g |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEC2PLhRqEAg4pLubhx8HhErLqktpQYVWvYXYsduVqk3Y7Ar1r_HrmHGcQFAFXHqJVvE4yo7H84hnviHk2VBwnWRiEMjc4DEjXBQTScCFFVZmVsUOZ_bgkO0dx-9Pk9Ml8qOphcG0ykYnOkWdFxq_kffB0wfjDMGB6FufFvFpd_Sm_BZgByk8aW3aadQism8uv0P4Vr0e78JaPw_D0bsvO3uB7zAQaCbDeaC0yIfhIEIp1NKqTJssUsnAWMUVG2qR5RC12dAOhdA5vjwC3IVCGJsIKRD0ANT_DR5xgXtM7LTpJaBHGPOlejCn7yVjqyymZgviHrAYsmMKXceA1i4slxdFdZXT-2fu5m_GcHSb3PJeLN2uxW6VLJnpGlk58Of0a2TVq4yKvvS41q_uEHUETmngIFppU5BJyxlOwpY_tLAUwTh0__yyLNwvaspJVeTwGNcTiRaLuceBrSh-QKZqUmJoTnOPIXqXHF_LAtwjy1Ng6TqhSQSWloU5swosM4tlnsUQzxqpjInBOe-RqOF2qj3-ObbhuEjdoR6HOKhmXoprlPo16pGgnVXW-B__oH-LC9nSInq3u1HMzlKvDFIWWpZleaS4AIdQSaV4JGP0XDn6w7xHNlEM0roUttVB6TYTIgIXMQKKp44CETymuBfOskVVpeOPJ_9B9PmoQ_TCE9kC2KEzX5YB_wmRwTqUGx1K0EO6M7yOQttwpUp_7ViY2Qjy1cNP2mF8KKb9TU2xqGkkWBwW9cj9Wu5bzkYxAk_hbN7ZER3Wd0emk3MHoC74UPKEP_j7a22SFdAw6Yfx4f5DcjPEXCYH8LlBluezhXkEzuhcPXa7npKv161mfgK7NJ9p |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-world+clinical+predictors+of+manic%2Fhypomanic+episodes+among+outpatients+with+bipolar+disorder&rft.jtitle=PloS+one&rft.au=Tokumitsu%2C+Keita&rft.au=Norio%2C+Yasui-Furukori&rft.au=Adachi%2C+Naoto&rft.au=Kubota%2C+Yukihisa&rft.date=2021-12-31&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=16&rft.issue=12&rft.spage=e0262129&rft_id=info:doi/10.1371%2Fjournal.pone.0262129&rft.externalDocID=A688366337 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |